US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CEL-SCI Corp

2.44

+0.03001.24%

Post-market: 2.42-0.0200-0.82%16:35 EDT

Volume:63.28K

Turnover:155.05K

Market Cap:12.53M

PE:-0.20

High:2.50

Open:2.41

Low:2.39

Close:2.41

Loading ...

Overview Company News Filings

CEL-SCI Announces Pricing of $2.5 Million Offering

CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks With Potential Partners Interested in Commercialization of Multikine

THOMSON REUTERS

CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks with Potential Partners Interested in Commercialization of Multikine

Journal of the American Medical Association (JAMA) Study Provides Further Evidence that CEL-SCI’s Multikine Can Treat Unmet Need in ~70% of Head and Neck Patients Based on PD-L1 Expression

Brazilian Fintech Meliuz Unveils Bitcoin Reserve Strategy

Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications

Brazil Shocks the Crypto World with First-Ever XRP Spot ETF Approval

Brazil Launches Innovative XRP ETF for Investors

Brazil Paves the Way for XRP ETF to Thrive in the Market

GERDAU S.A. - CONSOLIDATED INFORMATION

Press Release: CEL-SCI Reports Fiscal Q1 2025 Financial Results: Multikine Shows Pre-Surgical Tumor Elimination and Regression in Just 3 Weeks

Cel-Sci: Fiscal Q1 Earnings Snapshot

Associated Press Finance

CVM: Fiscal Year 2024 Results

Zacks Small Cap Research

Press Release: ITAÚ UNIBANCO - MATERIAL FACT - PROJECTIONS 2025

Top 3 Crypto Coins That Might See ETF Approval in 2025

CEL-SCI Q4 EPS $(0.09) Beats $(0.11) Estimate

CEL-SCI Reports Fiscal 2024 Results: Set to Commence Confirmatory Study That Could Bring New Standard of Care to Head & Neck Cancer

THOMSON REUTERS

Press Release: CEL-SCI Reports Fiscal 2024 Results: Set to Commence Confirmatory Study That Could Bring New Standard of Care to Head & Neck Cancer

FDA's Center for Veterinary Medicine Grants Innocan Pharma a Fee Waiver for 2025

BRIEF-CEL-SCI Announces Closing Of $5 Million Offering

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CVM/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CVM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CVM\",,,,,undefined,":{"symbol":"CVM","market":"US","secType":"STK","nameCN":"CEL-SCI Corp","latestPrice":2.44,"timestamp":1750968000000,"preClose":2.41,"halted":0,"volume":63280,"hourTrading":{"tag":"盘后","latestPrice":2.42,"preClose":2.44,"latestTime":"16:35 EDT","volume":4063,"amount":9832.5436978,"timestamp":1750970137445},"delay":0,"floatShares":5073200,"shares":5135021,"eps":-12.33156,"marketStatus":"Post-Mkt","change":0.03,"latestTime":"06-26 17:13:05 EDT","open":2.41,"high":2.5,"low":2.39,"amount":155045.52364,"amplitude":0.045643,"askPrice":2.48,"askSize":100,"bidPrice":2.22,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-12.33156,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1750982400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":433828800000,"exchange":"AMEX","adjPreClose":2.41,"preHourTrading":{"tag":"盘前","latestPrice":2.41,"preClose":2.4,"latestTime":"08:22 EDT","volume":1063,"amount":2538.5503000000003,"timestamp":1750940539365},"postHourTrading":{"tag":"盘后","latestPrice":2.42,"preClose":2.44,"latestTime":"16:35 EDT","volume":4063,"amount":9832.5436978,"timestamp":1750970137445},"volumeRatio":0.110739,"impliedVol":1.3611,"impliedVolPercentile":0.5644},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CVM\",,,,,undefined,":{"symbol":"CVM","floatShares":5073200,"roa":"-62.86%","roe":"-244.56%","lyrEps":-15.30942,"volumeRatio":0.110739,"shares":5135021,"dividePrice":0,"high":2.5,"amplitude":0.045643,"preClose":2.41,"low":2.39,"week52Low":1.98,"pbRate":"1.57","week52High":66.597,"institutionHeld":0.1743,"latestPrice":2.44,"eps":-12.33156,"divideRate":0,"volume":63280,"delay":0,"ttmEps":-12.33156,"open":2.41,"prevYearClose":11.997,"prevWeekClose":2.55,"prevMonthClose":2.1,"prevQuarterClose":6.912,"fiveDayClose":2.29,"twentyDayClose":2.5,"sixtyDayClose":6.912},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CVM\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520507822","title":"CEL-SCI Announces Pricing of $2.5 Million Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2520507822","media":"Business Wire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520507822?lang=en_us&edition=fundamental","pubTime":"2025-03-18 03:24","pubTimestamp":1742239440,"startTime":"0","endTime":"0","summary":"VIENNA, Va., March 17, 2025----CEL-SCI Corporation  , a Phase 3 cancer immunotherapy company, today announced the pricing of a best-efforts offering of 16,000,000 shares of its common stock . Total gross proceeds from the offering, before deducting the placement agent’s fees and other offering expenses, are expected to be approximately $2,560,000. The offering is expected to close on March 18, 2025, subject to satisfaction of customary closing conditions.The Company intends to use the net proceeds from the offering to fund the continued development of Multikine, general corporate purposes, and working capital.Multikine , given right after diagnosis and before surgery, has been dosed in over 740 patients and received Orphan Drug designation from the FDA for neoadjuvant therapy in patients with squamous cell carcinoma  of the head and neck. Based on the data from the completed randomized controlled Phase 3 study, the FDA concurred with CEL-SCI’s target patient selection criteria and gave","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cel-sci-announces-pricing-2-192400115.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CVM","BK4139"],"gpt_icon":0},{"id":"2520540898","title":"CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks With Potential Partners Interested in Commercialization of Multikine","url":"https://stock-news.laohu8.com/highlight/detail?id=2520540898","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520540898?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:03","pubTimestamp":1742213001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nFWN3Q010E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CVM"],"gpt_icon":0},{"id":"2520528101","title":"CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks with Potential Partners Interested in Commercialization of Multikine","url":"https://stock-news.laohu8.com/highlight/detail?id=2520528101","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520528101?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:00","pubTimestamp":1742212800,"startTime":"0","endTime":"0","summary":"Growing body of data on PD-L1 as a cancer biomarker spurs interest. Working towards partnership for non-dilutive funding of the final confirmatory head and neck cancer Registration Study. CEL-SCI completed a randomized controlled Phase 3 study conducted in 928 locally advanced, resectable head and neck cancer stage 3 and 4a patients in 23 countries on 3 continents. The Phase 3 study demonstrated strong statistical results and improved survival with Multikine neoadjuvant treatment over control. The 5-year survival rate of the target patient population that will be treated in the confirmatory Registration Study increased to 73% when patients were treated with Multikine before standard of care vs 45% for control patients who received only the standard of care treatments. The survival advantage over control was accentuated in patients who had low to zero expression of PD-L1 on their tumors and had lower disease burden by having N0 (no nodal inv","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cel-sci-head-neck-cancer-120000661.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4023","BK4585","BK4139","BK4613","CVM","BK4588","BK4528","SAP"],"gpt_icon":0},{"id":"2519804117","title":"Journal of the American Medical Association (JAMA) Study Provides Further Evidence that CEL-SCI’s Multikine Can Treat Unmet Need in ~70% of Head and Neck Patients Based on PD-L1 Expression","url":"https://stock-news.laohu8.com/highlight/detail?id=2519804117","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519804117?lang=en_us&edition=fundamental","pubTime":"2025-03-14 20:30","pubTimestamp":1741955400,"startTime":"0","endTime":"0","summary":"The DEPEND study demonstrates that checkpoint inhibitor nivolumab  works best with high levels of PD-L1 biomarker, but does not work well with low levels of PD-L1. Multikine aims to address a major treatment gap for head and neck cancer patients where about 70% have low PD-L1 expression, in its upcoming confirmatory Registration Trial. \"With these latest findings published in JAMA, industry is taking notice. We believe there is growing interest in Multikine as an advanced clinical stage asset that can prolong life for about 70% of head and neck cancer patients whose tumors have low PD-L1 expression,\" stated CEL-SCI’s CEO Geert Kersten.The DEPEND Phase 2 data also confirm the independent findings reviewed by the FDA’s recent Oncologic Advisory Committee meeting  on the use of checkpoint inhibitors including blockbuster drugs nivolumab and pembrolizumab, which appear to not work well in patients with low PD-L1 expression. To CEL-SCI’s knowledge, Multikine is the only oncology drug with s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/journal-american-medical-association-jama-123000995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4117","BK4139","BK4107","BK4023","LU1169589451.USD","LU1169590202.USD","PD","CVM","AFG"],"gpt_icon":0},{"id":"2517195476","title":"Brazilian Fintech Meliuz Unveils Bitcoin Reserve Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2517195476","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517195476?lang=en_us&edition=fundamental","pubTime":"2025-03-07 01:49","pubTimestamp":1741283392,"startTime":"0","endTime":"0","summary":"Meliuz, a Brazilian Fintech Company, has made a notable shift in diversifying its investments to feature Bitcoin. In a significant decision, Meliuz gave the nod to a new treasury strategy that would allow the company to set aside resources for Bitcoin  acquisition.According to the report, Meliuz has decided to seek long-term returns via Bitcoin. Hence, it will allow up to 10% of its cash to be invested in Bitcoin. Already, the company has made a significant purchase of 45.72 BTC for $4.1 million.Brazilian fintech unicorn Meliuz has adopted a Bitcoin treasury strategy, reportedly buying millions in BTC to maximize long-term shareholder value.#Bitcoin #Crypto #Meliuz #Brazilian. The initial 10% commitment from Meliuz could be increased to a higher percentage in the future. Notably, Meliuz’s board has called for a detailed analysis of this newly adopted approach and its profitability for the fintech firm.Given Brazil’s crypto-friendly atmosphere, there are speculations of possible digital","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/67c9e041325a5f5d96f1dfa4/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["MSTR","BK4585","BK4139","ETH.USD.HKCC","BK4596","APT.USD.CC","TON.USD.HKCC","IBIT","TON.USD.CC","ETH.USD.CC","BTC.USD.HKCC","BK4023","BK4588","BK4595","BK4594","STRK","BTC.USD.CC","BK4601","BK4516","BTC","MSTU","BK4600","APT.USD.HKCC","FTVI","CVM"],"gpt_icon":1},{"id":"2516673956","title":"Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2516673956","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516673956?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:30","pubTimestamp":1741091400,"startTime":"0","endTime":"0","summary":"Target Indications Include Microcystic Lymphatic Malformations, Venous Malformations and AngiofibromasProprietary Invisicare Delivery Technology Designed to Optimize Local Skin Penetration Company Pla","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/04/3036382/0/en/Quoin-Pharmaceuticals-Files-U-S-and-International-Patent-Applications-for-Novel-Topical-Rapamycin-Formulations-to-Treat-Rare-Disease-Indications.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVM","BK4139","QNRX"],"gpt_icon":0},{"id":"2512904412","title":"Brazil Shocks the Crypto World with First-Ever XRP Spot ETF Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2512904412","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512904412?lang=en_us&edition=fundamental","pubTime":"2025-02-20 18:13","pubTimestamp":1740046401,"startTime":"0","endTime":"0","summary":"Brazil just made crypto history. The country’s securities regulator, Comissão de Valores Mobiliários (CVM), has officially approved the world’s fir...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/brazil-shocks-the-crypto-world-with-first-ever-xrp-spot-etf-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/brazil-shocks-the-crypto-world-with-first-ever-xrp-spot-etf-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","FDN","BK4139","BK4550","CVM","BK4585"],"gpt_icon":0},{"id":"2512499204","title":"Brazil Launches Innovative XRP ETF for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2512499204","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512499204?lang=en_us&edition=fundamental","pubTime":"2025-02-20 14:49","pubTimestamp":1740034163,"startTime":"0","endTime":"0","summary":"You can also read this news on BH NEWS: Brazil Launches Innovative XRP ETF for Investors. Brazil is set to make waves in the cryptocurrency sector with the approval of its first exchange-traded fund  that features XRP. The Brazilian Securities and Exchange Commission  has given the green light for this fund, managed by Hashdex, to be listed on B3, the nation’s primary stock exchange. While the official trading date is yet to be confirmed, this move represents a significant milestone in Brazil’s evolving market for digital currencies.The XRP ETF, scheduled for launch on December 10, 2024, is rooted in the coin’s real-world applications and the rising demand from institutional players. Managed by Genial Investimentos, this fund aims to offer investors a fresh option, diversifying the cryptocurrency investment landscape.– Brazil is embracing a flexible regulatory stance on cryptocurrency. – The XRP ETF’s approval reflects an accommodating investment climate. – There is a notable rise in i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/67b6d076562ecd3af918975c/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["BK4585","FDN","CVM","BK4550","BK4211","ISBC","BK4139","BK4588"],"gpt_icon":0},{"id":"2512249499","title":"Brazil Paves the Way for XRP ETF to Thrive in the Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2512249499","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512249499?lang=en_us&edition=fundamental","pubTime":"2025-02-20 14:49","pubTimestamp":1740034163,"startTime":"0","endTime":"0","summary":"You can also read this news on COINTURK NEWS: Brazil Paves the Way for XRP ETF to Thrive in the Market. The Brazilian Securities and Exchange Commission  has approved the first exchange-traded fund  that includes XRP. Managed by Hashdex, this fund will be listed on the country’s main stock exchange platform, B3. Although the official start date for trading has not been finalized, this development showcases Brazil’s innovative approach to the cryptocurrency market. Regulatory frameworks for cryptocurrency investments in Brazil are observed to be more flexible, in contrast to similar applications still under review in the United States.The establishment date for the XRP-based ETF has been set for December 10, 2024. The real-world utility of XRP and the increasing institutional demand played significant roles in the creation of this fund, managed by Genial Investimentos. With the XRP ETF, Hashdex aims to provide investors with a new alternative and enhance diversity within the cryptocurre","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/67b6d076562ecd3af918975e/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["FDN","THAC","BK4588","BK4550","BK4585","CVM","BK4139"],"gpt_icon":0},{"id":"2512345455","title":"GERDAU S.A. - CONSOLIDATED INFORMATION","url":"https://stock-news.laohu8.com/highlight/detail?id=2512345455","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512345455?lang=en_us&edition=fundamental","pubTime":"2025-02-20 06:53","pubTimestamp":1740005580,"startTime":"0","endTime":"0","summary":"SO PAULO, Feb. 19, 2025 /PRNewswire/ --4Q24 Highlights. Adjusted EBITDA of R$ 2.4 billion in the fourth quarter, up 17.2% from 4Q23.Investments amounted to R$2.4 billion in 4Q24, totaling R$6.2 billion for 2024. For 2025, we estimate an investment of R$6 billion in projects allocated to maintenance and competitiveness.Dividend distribution in the amount of R$ 0.10 per share, equivalent to R$ 203.4 million, to be paid based on 4Q24 results. In 2024, Gerdau S.A.  returned R$2.9 billion through dividends and the buyback program, achieving a return of 65.9% for shareholders.The Company concluded the 2024 share buyback program and approved a new buyback program for up to 64.5 million shares of Gerdau S.A., with a 12-month term.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/gerdau-consolidated-information-225300924.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gerdau-consolidated-information-225300924.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","CVM","III","GGB","BK4115","BK4006","CNSL","LU0532187761.SGD","IE00B1B80R65.USD","BK4134","LU0210535034.USD"],"gpt_icon":0},{"id":"2512157767","title":"Press Release: CEL-SCI Reports Fiscal Q1 2025 Financial Results: Multikine Shows Pre-Surgical Tumor Elimination and Regression in Just 3 Weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2512157767","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512157767?lang=en_us&edition=fundamental","pubTime":"2025-02-18 21:30","pubTimestamp":1739885400,"startTime":"0","endTime":"0","summary":"CEL-SCI Reports Fiscal Q1 2025 Financial Results: Multikine Shows Pre-Surgical Tumor Elimination and Regression in Just 3 Weeks. CEL-SCI Corporation  today reported financial results for three months ended December 31, 2024, as well as key recent clinical and corporate developments.\"CEL-SCI is very uniquely positioned at this moment as an immuno-oncology company with a vast amount of data from the largest Phase 3 head and neck cancer study ever performed, with statistically significant evidence that our drug can successfully fight cancer and extend lives in head and neck cancer,\" stated CEL-SCI CEO, Geert Kersten. \"We hope to deliver a new standard of care to patients while substantially transforming our company's valuation to reflect what we believe to be the intrinsic value of our cancer drug. The statistical analysis shows that our very soon to be initiated small confirmatory Registration Study has a very high chance of success and we will have indications of efficacy as early as 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CEL","CVM","SAP","BK4588","BK4139","BK4528","BK4023","BK4585"],"gpt_icon":0},{"id":"2511101716","title":"Cel-Sci: Fiscal Q1 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2511101716","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511101716?lang=en_us&edition=fundamental","pubTime":"2025-02-15 05:24","pubTimestamp":1739568253,"startTime":"0","endTime":"0","summary":"VIENNA, Va.  — VIENNA, Va.  — Cel-Sci Corp.  on Friday reported a loss of $7.1 million in its fiscal first quarter.The Vienna, Virginia-based company said it had a loss of 11 cents per share.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cel-sci-fiscal-q1-earnings-212413365.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CVM"],"gpt_icon":0},{"id":"2510639918","title":"CVM: Fiscal Year 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2510639918","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510639918?lang=en_us&edition=fundamental","pubTime":"2025-02-10 17:15","pubTimestamp":1739178900,"startTime":"0","endTime":"0","summary":"CEL-SCI Corporation  reports fiscal year 2024 financial and operational results. The press release and Form 10-K filing encapsulate a year of preparation for confirmatory registration studies around the globe. CEL-SCI cleared its proposed 212-patient registration study of Multikine with the FDA. This narrowed the population to patients with squamous cell carcinoma of the head and neck  with no lymph node involvement and low PD-L1 tumor expression. A contract research organization  was selected to run the trial and data was presented from the IT-MATTERS study showing 73% survival for Multikine vs. 45% in the control arm at five years. Outside of the US, the European Medicines Agency  Pediatric Committee and the United Kingdom’s Healthcare Products Regulatory Agency  granted Multikine a pediatric waiver, streamlining the process for obtaining approval in these jurisdictions.CEL-SCI recognized no revenues for its fiscal year ending September 30, 2024. It consumed $26.4 million in operatio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cvm-fiscal-2024-results-091500108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4097","BK4139","CVM","OS"],"gpt_icon":0},{"id":"2509263634","title":"Press Release: ITAÚ UNIBANCO - MATERIAL FACT - PROJECTIONS 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2509263634","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509263634?lang=en_us&edition=fundamental","pubTime":"2025-02-06 07:23","pubTimestamp":1738797780,"startTime":"0","endTime":"0","summary":"SO PAULO, Feb. 5, 2025 /PRNewswire/ -- Itaú Unibanco Holding S.A. , in compliance with the provisions of Article 157, paragraph 4 of Law No. 6,404/76 and Resolution No. 44/21 of the Brazilian Securities and Exchange Commission , informs its stockholders and the market in general that it released as of this date its projections for the year 2025 in accordance with item 3  of the Reference Form.It is important to mention that, as of February 2025, the company considers a cost of capital of around 15.0% p.y. in the management of its businesses.Information on outlooks for the business, projections, and operational and financial goals are solely forecasts, based on management's current outlook in relation to the future of Itaú Unibanco. These expectations are highly dependent on market conditions, the general economic performance of the country, of the sector and the international markets. Therefore, our effective results and performance may differ from those forecasted in this prospective ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ITUB","LU0050427557.USD","BK4207","LU0229945570.USD","LU0543330566.HKD","LU0029865408.USD","FACT","LU0572108347.SGD","LU0265266980.USD","LU0228659784.USD","LU0106259046.USD","IE00B1B80R65.USD","BK4139","CVM","IE00B0JY6N72.USD","LU0072463663.USD","BK4588","LU0788109048.HKD","LU0256859116.SGD","BK4585","LU0456842615.SGD","ITA","LU0128526570.USD","LU0532187761.SGD","LU0320763518.SGD"],"gpt_icon":0},{"id":"2503179998","title":"Top 3 Crypto Coins That Might See ETF Approval in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503179998","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503179998?lang=en_us&edition=fundamental","pubTime":"2025-01-16 19:54","pubTimestamp":1737028487,"startTime":"0","endTime":"0","summary":"2024 was a great year for the ETF market, as Crypto King Bitcoin got approval for its Spot ETF after much struggle and delay. With bullish sentiments riding high in 2025, experts believe this will be a great year for the crypto industry with the community expecting to witness more ETFs to be approved.Rewinding the clock to early January 2024, the world witnessed the debut of U.S. spot bitcoin exchange-traded funds, probably one of the biggest events in the sector. In the very first year, the BTC ETF pulled in $30 billion in revenue, as a testament to the growing popularity of ETFs.Geraci anticipates Solana and XRP ETFs but Regulatory hurdles may create delay. Besides this Bloomberg analysts Eric Balchunas and James Seyffart believe Litecoin and Hedera have a better chance of getting a ETF approval.Moreover, banking giant JPMorgan predicted that Solana and XRP ETFs may attract billions in new investment if approved. As community is expecting a crypto-friendly regulatory regime in the US","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/6788f389bf67320a339f9dc8/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["ETH.USD.CC","EZET","FDN","APT.USD.HKCC","ETHV","BTC.USD.CC","BTC.USD.HKCC","BK4550","CVM","FETH","ETH.USD.HKCC","BK4601","BK4594","RNDR.USD.HKCC","APT.USD.CC","LDO.USD.HKCC","TON.USD.CC","TON.USD.HKCC","QETH","BK4588","BK4585","LTC.USD.CC","CETH","LTC.USD.HKCC","BK4139"],"gpt_icon":1},{"id":"2503576780","title":"CEL-SCI Q4 EPS $(0.09) Beats $(0.11) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2503576780","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503576780?lang=en_us&edition=fundamental","pubTime":"2025-01-14 22:20","pubTimestamp":1736864421,"startTime":"0","endTime":"0","summary":"CEL-SCI (AMEX:CVM) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 43.75 percent increase over losses of $(0.16) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/01/42974613/cel-sci-q4-eps-0-09-beats-0-11-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CEL","CVM"],"gpt_icon":0},{"id":"2503575413","title":"CEL-SCI Reports Fiscal 2024 Results: Set to Commence Confirmatory Study That Could Bring New Standard of Care to Head & Neck Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2503575413","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503575413?lang=en_us&edition=fundamental","pubTime":"2025-01-14 22:00","pubTimestamp":1736863206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nTUAB9BWRW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CVM"],"gpt_icon":0},{"id":"2503575421","title":"Press Release: CEL-SCI Reports Fiscal 2024 Results: Set to Commence Confirmatory Study That Could Bring New Standard of Care to Head & Neck Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2503575421","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503575421?lang=en_us&edition=fundamental","pubTime":"2025-01-14 22:00","pubTimestamp":1736863200,"startTime":"0","endTime":"0","summary":"CEL-SCI Reports Fiscal 2024 Results: Set to Commence Confirmatory Study That Could Bring New Standard of Care to Head & Neck Cancer. A 212-patient Confirmatory Registration Study for Multikine in PD-L1. low newly diagnosed head and neck cancer patients is currently in final. stage of start-up preparations - full enrollment expected by Q2 2026. Plans to seek early approval based on pre-surgical response rates. A positive study outcome will position Multikine as the first treatment. in over 50 years for newly diagnosed locally advanced head and neck. cancer patients -- a population with a severe unmet medical need. via biopsy). In this target population in the completed Phase 3 study,CEL-SCI selected Ergomed, a clinical research organization  with a","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4124","BK4156","CEL","SMP","BK4139","CVM"],"gpt_icon":0},{"id":"2502020760","title":"FDA's Center for Veterinary Medicine Grants Innocan Pharma a Fee Waiver for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2502020760","media":"CNW Group","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502020760?lang=en_us&edition=fundamental","pubTime":"2025-01-10 05:01","pubTimestamp":1736456460,"startTime":"0","endTime":"0","summary":"HERZLIYA, Israel and CALGARY, Alberta, Jan. 9, 2025 /CNW/ -- Innocan Pharma Corporation    , a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that the FDA's Center for Veterinary Medicine  has granted the Company a sponsor fee waiver for its LPT-CBD  product for the second consecutive year.The Animal Drug User Fee Act  authorizes the FDA's Center for Veterinary Medicine  to collect user fees for certain animal drug applications on an annual basis. Under this Act, sponsors may request a yearly fee waiver through the 'significant barrier to innovation' provision. Following a thorough review, the CVM granted Innocan the 2025 fee waiver, recognizing the Company's continued pursuit of innovative animal drug products and technology.Dr. Eyal Kalo, R&D Director at Innocan further added, \"The fee waiver granted by the Center for Veterinary Medicine  for the second time underscores their continued recognition and support of our efforts to advance LPT-CBD devel","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fdas-center-veterinary-medicine-grants-210100877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4557","INN","BK4139","INNPF","BK4218","BK4007","ACB","BK4181","CVM"],"gpt_icon":0},{"id":"2500626744","title":"BRIEF-CEL-SCI Announces Closing Of $5 Million Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2500626744","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500626744?lang=en_us&edition=fundamental","pubTime":"2025-01-01 06:48","pubTimestamp":1735685288,"startTime":"0","endTime":"0","summary":"BRIEF-CEL-SCI Announces Closing Of $5 Million OfferingDec 31 (Reuters) - CEL-SCI Corp CVM.A:CEL-SCI ANNOUNCES CLOSING OF $5 MILLION OFFERINGSource text: ID:nBw6dJ7LaFurther company coverage: CVM.A ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241231:nTUAHM7N0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CVM"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":71,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CVM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-20","symbol":"CVM","defaultRemindTime":1747747800000,"type":"split","dateTimestamp":1747713600000,"forFactor":30,"toFactor":1,"ratio":30},{"market":"US","date":"2025-05-14","symbol":"CVM","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.08},{"market":"US","date":"2025-02-14","symbol":"CVM","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739509200000,"reportTimeType":"post","actualEps":-0.11},{"market":"US","date":"2025-01-13","symbol":"CVM","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1736744400000,"reportTimeType":"post","actualEps":-0.09},{"date":"2024-08-15","symbol":"CVM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/06","expectedEps":-0.13,"defaultRemindTime":1723708800000,"name":null,"time":"Pre-Market","dateTimestamp":1723694400000,"actualEps":-0.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CVM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CVM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1741665600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CVM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CVM","date":"2025-06-25","current":-0.45756,"percent":0.991064,"low":-36.303853,"twenty":-15.420255,"median":-3.816287,"eighty":-2.18986,"high":-0.395422,"avg":-7.620136,"sd":7.629699,"marketCap":12478101},"quantilePoints":[{"date":"2020-06-26","current":-18.189136,"twenty":-8.062403,"median":-2.479965,"eighty":-0.817762,"marketCap":573540544},{"date":"2020-07-02","current":-16.529405,"twenty":-8.151538,"median":-2.479965,"eighty":-0.817762,"marketCap":521205853},{"date":"2020-07-10","current":-17.470103,"twenty":-8.186901,"median":-2.479965,"eighty":-0.817762,"marketCap":550867974},{"date":"2020-07-17","current":-17.665573,"twenty":-8.266839,"median":-2.479965,"eighty":-0.817762,"marketCap":557031532},{"date":"2020-07-24","current":-16.236201,"twenty":-8.314192,"median":-2.479965,"eighty":-0.817762,"marketCap":511960516},{"date":"2020-07-31","current":-15.283286,"twenty":-8.342981,"median":-2.479965,"eighty":-0.817762,"marketCap":481913172},{"date":"2020-08-07","current":-14.892347,"twenty":-8.412596,"median":-2.479965,"eighty":-0.817762,"marketCap":469586056},{"date":"2020-08-14","current":-16.503475,"twenty":-8.470363,"median":-2.479965,"eighty":-0.817762,"marketCap":490912107},{"date":"2020-08-21","current":-16.555414,"twenty":-8.562705,"median":-2.479965,"eighty":-0.817762,"marketCap":492457071},{"date":"2020-08-28","current":-17.503292,"twenty":-8.806363,"median":-2.479965,"eighty":-0.817762,"marketCap":520652652},{"date":"2020-09-04","current":-17.607169,"twenty":-8.984749,"median":-2.479965,"eighty":-0.817762,"marketCap":523742579},{"date":"2020-09-11","current":-17.204646,"twenty":-9.06225,"median":-2.479965,"eighty":-0.817762,"marketCap":511769113},{"date":"2020-09-18","current":-18.619971,"twenty":-9.115153,"median":-2.479965,"eighty":-0.817762,"marketCap":553869364},{"date":"2020-09-25","current":-16.51646,"twenty":-9.194573,"median":-2.479965,"eighty":-0.817762,"marketCap":491298348},{"date":"2020-10-02","current":-17.620154,"twenty":-9.28401,"median":-2.479965,"eighty":-0.817762,"marketCap":524128819},{"date":"2020-10-09","current":-19.308157,"twenty":-9.372965,"median":-2.479965,"eighty":-0.817762,"marketCap":574340129},{"date":"2020-10-16","current":-20.80139,"twenty":-9.416922,"median":-2.479965,"eighty":-0.817762,"marketCap":618757825},{"date":"2020-10-23","current":-17.022861,"twenty":-9.659475,"median":-2.479965,"eighty":-0.817762,"marketCap":506361741},{"date":"2020-10-30","current":-15.665686,"twenty":-9.745942,"median":-2.479965,"eighty":-0.817762,"marketCap":465991240},{"date":"2020-11-06","current":-15.066665,"twenty":-9.920207,"median":-2.479965,"eighty":-0.817762,"marketCap":448172789},{"date":"2020-11-13","current":-16.499106,"twenty":-10.207212,"median":-2.479965,"eighty":-0.817762,"marketCap":490782129},{"date":"2020-11-20","current":-15.900085,"twenty":-10.500982,"median":-2.479965,"eighty":-0.817762,"marketCap":472963678},{"date":"2020-11-27","current":-16.850704,"twenty":-10.692293,"median":-2.479965,"eighty":-0.817762,"marketCap":501240786},{"date":"2020-12-04","current":-15.652664,"twenty":-11.010512,"median":-2.479965,"eighty":-0.817762,"marketCap":465603883},{"date":"2020-12-11","current":-19.339597,"twenty":-11.212214,"median":-2.482557,"eighty":-0.817762,"marketCap":575275353},{"date":"2020-12-18","current":-17.48182,"twenty":-12.418034,"median":-2.492735,"eighty":-0.817762,"marketCap":520013934},{"date":"2020-12-24","current":-17.120957,"twenty":-12.792988,"median":-2.500417,"eighty":-0.817762,"marketCap":509279701},{"date":"2020-12-31","current":-15.310637,"twenty":-13.515253,"median":-2.518522,"eighty":-0.817762,"marketCap":463559822},{"date":"2021-01-08","current":-18.25196,"twenty":-13.798902,"median":-2.526554,"eighty":-0.817762,"marketCap":552614196},{"date":"2021-01-15","current":-18.742981,"twenty":-14.056407,"median":-2.535735,"eighty":-0.817762,"marketCap":567480812},{"date":"2021-01-22","current":-18.716712,"twenty":-14.394355,"median":-2.535735,"eighty":-0.817762,"marketCap":566685464},{"date":"2021-01-29","current":-32.770663,"twenty":-14.574252,"median":-2.535735,"eighty":-0.817762,"marketCap":992196654},{"date":"2021-02-05","current":-30.984367,"twenty":-14.773602,"median":-2.535735,"eighty":-0.817762,"marketCap":938112989},{"date":"2021-02-12","current":-29.127713,"twenty":-14.836217,"median":-2.557047,"eighty":-0.817762,"marketCap":954464496},{"date":"2021-02-19","current":-24.539016,"twenty":-14.892347,"median":-2.570115,"eighty":-0.817762,"marketCap":804100875},{"date":"2021-02-26","current":-21.954009,"twenty":-14.992143,"median":-2.570115,"eighty":-0.817762,"marketCap":719394684},{"date":"2021-03-05","current":-24.019541,"twenty":-15.091995,"median":-2.57578,"eighty":-0.817762,"marketCap":787078578},{"date":"2021-03-12","current":-25.293492,"twenty":-15.193271,"median":-2.602518,"eighty":-0.817762,"marketCap":828823735},{"date":"2021-03-19","current":-21.892166,"twenty":-15.25121,"median":-2.616574,"eighty":-0.817762,"marketCap":717368220},{"date":"2021-03-26","current":-20.333741,"twenty":-15.328113,"median":-2.629256,"eighty":-0.818503,"marketCap":666301330},{"date":"2021-04-01","current":-20.370846,"twenty":-15.523478,"median":-2.642183,"eighty":-0.818503,"marketCap":667517208},{"date":"2021-04-09","current":-19.950319,"twenty":-15.637604,"median":-2.682036,"eighty":-0.817762,"marketCap":653737254},{"date":"2021-04-16","current":-21.607692,"twenty":-15.727789,"median":-2.952382,"eighty":-0.817762,"marketCap":708046486},{"date":"2021-04-23","current":-30.203768,"twenty":-15.842734,"median":-3.11969,"eighty":-0.817762,"marketCap":989724968},{"date":"2021-04-30","current":-29.845083,"twenty":-15.945112,"median":-3.220938,"eighty":-0.817762,"marketCap":977971478},{"date":"2021-05-07","current":-26.456126,"twenty":-16.001259,"median":-3.342026,"eighty":-0.817762,"marketCap":866921256},{"date":"2021-05-14","current":-27.618761,"twenty":-16.12622,"median":-3.420304,"eighty":-0.817762,"marketCap":905018777},{"date":"2021-05-21","current":-24.359361,"twenty":-16.194926,"median":-3.471932,"eighty":-0.817762,"marketCap":850039002},{"date":"2021-05-28","current":-25.215104,"twenty":-16.242394,"median":-3.499441,"eighty":-0.817762,"marketCap":879900815},{"date":"2021-06-04","current":-28.978027,"twenty":-16.27136,"median":-3.562279,"eighty":-0.817762,"marketCap":1011210978},{"date":"2021-06-11","current":-27.068328,"twenty":-16.313109,"median":-3.626813,"eighty":-0.817762,"marketCap":944570533},{"date":"2021-06-18","current":-27.019578,"twenty":-16.463579,"median":-3.656855,"eighty":-0.817762,"marketCap":942869371},{"date":"2021-06-25","current":-30.566127,"twenty":-16.539276,"median":-3.704254,"eighty":-0.817762,"marketCap":1066628950},{"date":"2021-07-02","current":-9.859342,"twenty":-16.554579,"median":-3.81599,"eighty":-0.817762,"marketCap":344049473},{"date":"2021-07-09","current":-10.888143,"twenty":-16.554579,"median":-3.886922,"eighty":-0.817762,"marketCap":379950287},{"date":"2021-07-16","current":-9.712371,"twenty":-16.554579,"median":-3.975297,"eighty":-0.817762,"marketCap":338920785},{"date":"2021-07-23","current":-9.40618,"twenty":-16.554579,"median":-4.078552,"eighty":-0.817762,"marketCap":328236019},{"date":"2021-07-30","current":-9.834847,"twenty":-16.554579,"median":-4.143086,"eighty":-0.817762,"marketCap":343194691},{"date":"2021-08-06","current":-11.231077,"twenty":-16.554579,"median":-4.233433,"eighty":-0.817762,"marketCap":391917226},{"date":"2021-08-13","current":-11.466148,"twenty":-16.554579,"median":-4.310874,"eighty":-0.817762,"marketCap":388544194},{"date":"2021-08-20","current":-12.10104,"twenty":-16.554579,"median":-4.432946,"eighty":-0.817762,"marketCap":410058269},{"date":"2021-08-27","current":-13.700968,"twenty":-16.554579,"median":-4.607581,"eighty":-0.817762,"marketCap":464273738},{"date":"2021-09-03","current":-14.615212,"twenty":-16.554579,"median":-4.744934,"eighty":-0.817762,"marketCap":495254006},{"date":"2021-09-10","current":-14.577119,"twenty":-16.554579,"median":-4.782394,"eighty":-0.817762,"marketCap":493963162},{"date":"2021-09-17","current":-15.440572,"twenty":-16.554579,"median":-4.949865,"eighty":-0.817762,"marketCap":523222304},{"date":"2021-09-24","current":-15.173917,"twenty":-16.554579,"median":-5.094561,"eighty":-0.817762,"marketCap":514186392},{"date":"2021-10-01","current":-14.462838,"twenty":-16.554579,"median":-5.319321,"eighty":-0.817762,"marketCap":490090628},{"date":"2021-10-08","current":-12.862911,"twenty":-16.554579,"median":-5.785203,"eighty":-0.817762,"marketCap":435875159},{"date":"2021-10-15","current":-13.205752,"twenty":-16.554579,"median":-6.107319,"eighty":-0.817762,"marketCap":447492760},{"date":"2021-10-22","current":-14.500932,"twenty":-16.554579,"median":-6.705482,"eighty":-0.817762,"marketCap":491381473},{"date":"2021-10-29","current":-14.221579,"twenty":-16.554579,"median":-7.035014,"eighty":-0.817762,"marketCap":481915280},{"date":"2021-11-05","current":-15.2755,"twenty":-16.554579,"median":-7.331381,"eighty":-0.817762,"marketCap":517628644},{"date":"2021-11-12","current":-15.478665,"twenty":-16.554579,"median":-7.497948,"eighty":-0.817762,"marketCap":524513148},{"date":"2021-11-19","current":-13.942227,"twenty":-16.554579,"median":-7.614194,"eighty":-0.817762,"marketCap":472449087},{"date":"2021-11-26","current":-12.977191,"twenty":-16.554579,"median":-7.668581,"eighty":-0.817762,"marketCap":439747693},{"date":"2021-12-03","current":-10.843954,"twenty":-16.554579,"median":-7.788232,"eighty":-0.827975,"marketCap":367460401},{"date":"2021-12-10","current":-11.237587,"twenty":-16.554579,"median":-7.8854,"eighty":-0.859111,"marketCap":380799127},{"date":"2021-12-17","current":-10.323343,"twenty":-16.554579,"median":-7.988477,"eighty":-0.879153,"marketCap":349818859},{"date":"2021-12-23","current":-9.859358,"twenty":-16.554579,"median":-8.049389,"eighty":-0.891677,"marketCap":361956448},{"date":"2021-12-31","current":-8.363374,"twenty":-16.554579,"median":-8.158065,"eighty":-0.93448,"marketCap":307035935},{"date":"2022-01-07","current":-7.291449,"twenty":-16.554301,"median":-8.158065,"eighty":-0.951103,"marketCap":267683442},{"date":"2022-01-14","current":-7.786183,"twenty":-16.554301,"median":-8.158065,"eighty":-0.96443,"marketCap":285846131},{"date":"2022-01-21","current":-6.643582,"twenty":-16.554301,"median":-8.158065,"eighty":-0.990095,"marketCap":243898968},{"date":"2022-01-28","current":-6.737817,"twenty":-16.554301,"median":-8.158065,"eighty":-1.013469,"marketCap":247358528},{"date":"2022-02-04","current":-6.584685,"twenty":-16.554301,"median":-8.158065,"eighty":-1.027849,"marketCap":241736743},{"date":"2022-02-11","current":-6.501997,"twenty":-16.554301,"median":-8.158065,"eighty":-1.040287,"marketCap":243642404},{"date":"2022-02-18","current":-6.132434,"twenty":-16.554301,"median":-8.158065,"eighty":-1.062721,"marketCap":229794168},{"date":"2022-02-25","current":-6.490448,"twenty":-16.554301,"median":-8.158065,"eighty":-1.085691,"marketCap":243209647},{"date":"2022-03-04","current":-5.728225,"twenty":-16.554301,"median":-8.158065,"eighty":-1.106996,"marketCap":214647660},{"date":"2022-03-11","current":-5.312467,"twenty":-16.554301,"median":-8.158065,"eighty":-1.158225,"marketCap":199068394},{"date":"2022-03-18","current":-5.77442,"twenty":-16.554301,"median":-8.158065,"eighty":-1.189564,"marketCap":216378690},{"date":"2022-03-25","current":-4.619536,"twenty":-16.554301,"median":-8.158065,"eighty":-1.226566,"marketCap":173102952},{"date":"2022-04-01","current":-4.515597,"twenty":-16.554301,"median":-8.158065,"eighty":-1.233418,"marketCap":169208135},{"date":"2022-04-08","current":-4.527145,"twenty":-16.554301,"median":-8.158065,"eighty":-1.247123,"marketCap":169640892},{"date":"2022-04-14","current":-3.811117,"twenty":-16.554301,"median":-8.158065,"eighty":-1.26768,"marketCap":142809935},{"date":"2022-04-22","current":-3.314517,"twenty":-16.554301,"median":-8.158065,"eighty":-1.280014,"marketCap":124201368},{"date":"2022-04-29","current":-3.306011,"twenty":-16.554301,"median":-8.158065,"eighty":-1.300358,"marketCap":123882641},{"date":"2022-05-06","current":-3.525642,"twenty":-16.554301,"median":-8.158065,"eighty":-1.396504,"marketCap":132112607},{"date":"2022-05-13","current":-3.408543,"twenty":-16.554301,"median":-8.158065,"eighty":-1.567315,"marketCap":123048702},{"date":"2022-05-20","current":-3.756599,"twenty":-16.554301,"median":-8.158065,"eighty":-1.692999,"marketCap":135613535},{"date":"2022-05-27","current":-4.188668,"twenty":-16.554301,"median":-8.158065,"eighty":-1.773964,"marketCap":151211257},{"date":"2022-06-03","current":-4.464712,"twenty":-16.554301,"median":-8.158065,"eighty":-1.827608,"marketCap":161176469},{"date":"2022-06-10","current":-4.020641,"twenty":-16.554301,"median":-8.158065,"eighty":-1.879456,"marketCap":145145476},{"date":"2022-06-17","current":-4.716752,"twenty":-16.554301,"median":-8.158065,"eighty":-1.922204,"marketCap":170275141},{"date":"2022-06-24","current":-5.388859,"twenty":-16.554579,"median":-8.158065,"eighty":-1.986916,"marketCap":194538265},{"date":"2022-07-01","current":-4.920909,"twenty":-16.554579,"median":-8.158065,"eighty":-2.104754,"marketCap":177645226},{"date":"2022-07-08","current":-5.545024,"twenty":-16.554579,"median":-8.158065,"eighty":-2.147391,"marketCap":200175840},{"date":"2022-07-15","current":-4.608851,"twenty":-16.554579,"median":-8.158065,"eighty":-2.267774,"marketCap":166379919},{"date":"2022-07-22","current":-4.584847,"twenty":-16.554579,"median":-8.158065,"eighty":-2.342744,"marketCap":165513357},{"date":"2022-07-29","current":-4.596849,"twenty":-16.554579,"median":-8.158065,"eighty":-2.385632,"marketCap":165946638},{"date":"2022-08-05","current":-5.052933,"twenty":-16.554579,"median":-8.158065,"eighty":-2.441697,"marketCap":182411317},{"date":"2022-08-12","current":-4.922494,"twenty":-16.554579,"median":-8.158065,"eighty":-2.459289,"marketCap":180842316},{"date":"2022-08-19","current":-5.170389,"twenty":-16.554579,"median":-8.158065,"eighty":-2.496095,"marketCap":189949483},{"date":"2022-08-26","current":-4.62738,"twenty":-16.554579,"median":-8.158065,"eighty":-2.52589,"marketCap":170000451},{"date":"2022-09-02","current":-4.532944,"twenty":-16.554579,"median":-8.158065,"eighty":-2.565239,"marketCap":166531054},{"date":"2022-09-09","current":-4.957907,"twenty":-16.554579,"median":-8.158065,"eighty":-2.577527,"marketCap":182143340},{"date":"2022-09-16","current":-4.875276,"twenty":-16.554579,"median":-8.158065,"eighty":-2.615174,"marketCap":179107618},{"date":"2022-09-23","current":-4.131589,"twenty":-16.554579,"median":-8.158065,"eighty":-2.629256,"marketCap":151786117},{"date":"2022-09-30","current":-3.647603,"twenty":-16.554579,"median":-8.158065,"eighty":-2.650331,"marketCap":134005457},{"date":"2022-10-07","current":-3.989935,"twenty":-16.554579,"median":-8.158065,"eighty":-2.709192,"marketCap":146582021},{"date":"2022-10-14","current":-3.730235,"twenty":-16.554579,"median":-8.158065,"eighty":-2.97036,"marketCap":137041179},{"date":"2022-10-21","current":-3.541362,"twenty":-16.554579,"median":-8.158065,"eighty":-3.086022,"marketCap":130102386},{"date":"2022-10-28","current":-4.10798,"twenty":-16.554579,"median":-8.158065,"eighty":-3.173453,"marketCap":150918767},{"date":"2022-11-04","current":-4.084371,"twenty":-16.554579,"median":-8.158065,"eighty":-3.238566,"marketCap":150051418},{"date":"2022-11-11","current":-3.97813,"twenty":-16.554579,"median":-8.158065,"eighty":-3.306011,"marketCap":146148346},{"date":"2022-11-18","current":-3.505949,"twenty":-16.554579,"median":-8.158065,"eighty":-3.349291,"marketCap":128801362},{"date":"2022-11-25","current":-3.564971,"twenty":-16.554579,"median":-8.158065,"eighty":-3.375176,"marketCap":130969735},{"date":"2022-12-02","current":-3.423317,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":125765639},{"date":"2022-12-09","current":-2.821285,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":103648234},{"date":"2022-12-16","current":-2.455345,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":90204320},{"date":"2022-12-23","current":-2.70324,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":99311487},{"date":"2022-12-30","current":-2.727829,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":102647678},{"date":"2023-01-06","current":-2.890338,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":108762858},{"date":"2023-01-13","current":-3.319826,"twenty":-16.554579,"median":-8.158065,"eighty":-3.422112,"marketCap":124924408},{"date":"2023-01-20","current":-3.296611,"twenty":-16.554579,"median":-8.158065,"eighty":-3.423904,"marketCap":124050810},{"date":"2023-01-27","current":-3.180533,"twenty":-16.554579,"median":-8.158065,"eighty":-3.423904,"marketCap":119682824},{"date":"2023-02-03","current":-3.110886,"twenty":-16.554579,"median":-8.158065,"eighty":-3.423904,"marketCap":117062032},{"date":"2023-02-10","current":-3.238572,"twenty":-16.554579,"median":-8.158065,"eighty":-3.423904,"marketCap":121866817},{"date":"2023-02-17","current":-3.60613,"twenty":-16.554579,"median":-8.158065,"eighty":-3.425791,"marketCap":132966149},{"date":"2023-02-24","current":-3.096052,"twenty":-16.554579,"median":-8.158065,"eighty":-3.427633,"marketCap":114158437},{"date":"2023-03-03","current":-3.511232,"twenty":-16.554579,"median":-8.158065,"eighty":-3.434617,"marketCap":129467040},{"date":"2023-03-10","current":-2.799496,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":103223721},{"date":"2023-03-17","current":-2.633424,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":97100280},{"date":"2023-03-24","current":-2.680873,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":98849834},{"date":"2023-03-31","current":-2.752046,"twenty":-16.554301,"median":-8.158065,"eighty":-3.436757,"marketCap":101474166},{"date":"2023-04-06","current":-2.704597,"twenty":-16.554301,"median":-8.158065,"eighty":-3.436757,"marketCap":99724612},{"date":"2023-04-14","current":-2.884201,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":106347001},{"date":"2023-04-21","current":-3.109715,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":114662198},{"date":"2023-04-28","current":-2.528127,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":93217741},{"date":"2023-05-05","current":-2.885438,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":106392623},{"date":"2023-05-12","current":-3.28552,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":121144541},{"date":"2023-05-19","current":-3.220882,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":113992096},{"date":"2023-05-26","current":-2.969054,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":105079495},{"date":"2023-06-02","current":-3.04486,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":107762376},{"date":"2023-06-09","current":-3.221739,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":114022431},{"date":"2023-06-16","current":-3.04486,"twenty":-16.554579,"median":-8.158065,"eighty":-3.438897,"marketCap":107762376},{"date":"2023-06-23","current":-2.842711,"twenty":-16.554858,"median":-8.158065,"eighty":-3.438897,"marketCap":100608027},{"date":"2023-06-30","current":-3.006957,"twenty":-16.555136,"median":-8.158065,"eighty":-3.445225,"marketCap":106420936},{"date":"2023-07-07","current":-3.095397,"twenty":-16.555136,"median":-8.158065,"eighty":-3.445225,"marketCap":109550963},{"date":"2023-07-14","current":-2.95642,"twenty":-16.555136,"median":-8.158065,"eighty":-3.445225,"marketCap":104632348},{"date":"2023-07-21","current":-2.63008,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":93082691},{"date":"2023-07-28","current":-2.282963,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":80797665},{"date":"2023-08-04","current":-2.096054,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":74182652},{"date":"2023-08-11","current":-1.895794,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":67095137},{"date":"2023-08-18","current":-1.746139,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":59075121},{"date":"2023-08-25","current":-1.899799,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":64273731},{"date":"2023-09-01","current":-1.941706,"twenty":-16.555136,"median":-8.158065,"eighty":-3.470535,"marketCap":65691534},{"date":"2023-09-08","current":-1.788046,"twenty":-16.555136,"median":-8.158065,"eighty":-3.438897,"marketCap":60492924},{"date":"2023-09-15","current":-1.732169,"twenty":-16.555136,"median":-8.158065,"eighty":-3.424794,"marketCap":58602520},{"date":"2023-09-22","current":-1.704231,"twenty":-16.555136,"median":-8.158065,"eighty":-3.408904,"marketCap":57657318},{"date":"2023-09-29","current":-1.690262,"twenty":-16.555136,"median":-8.158065,"eighty":-3.359935,"marketCap":57184717},{"date":"2023-10-06","current":-1.522633,"twenty":-16.555136,"median":-8.158065,"eighty":-3.340953,"marketCap":51513505},{"date":"2023-10-13","current":-1.648355,"twenty":-16.555136,"median":-8.158065,"eighty":-3.323464,"marketCap":55766914},{"date":"2023-10-20","current":-1.578509,"twenty":-16.555136,"median":-8.158065,"eighty":-3.306452,"marketCap":53403909},{"date":"2023-10-27","current":-1.88583,"twenty":-16.555414,"median":-8.188189,"eighty":-3.305529,"marketCap":63801130},{"date":"2023-11-03","current":-2.584285,"twenty":-16.555414,"median":-8.188189,"eighty":-3.27978,"marketCap":87431179},{"date":"2023-11-10","current":-3.338617,"twenty":-16.555414,"median":-8.188189,"eighty":-3.268215,"marketCap":112951631},{"date":"2023-11-17","current":-3.115111,"twenty":-16.555414,"median":-8.188189,"eighty":-3.261184,"marketCap":105390016},{"date":"2023-11-24","current":-3.72287,"twenty":-16.555414,"median":-8.188189,"eighty":-3.259721,"marketCap":125951626},{"date":"2023-12-01","current":-3.323991,"twenty":-16.555414,"median":-8.188189,"eighty":-3.259721,"marketCap":112456809},{"date":"2023-12-08","current":-3.841056,"twenty":-16.555414,"median":-8.181747,"eighty":-3.259642,"marketCap":129950090},{"date":"2023-12-15","current":-4.180842,"twenty":-16.555414,"median":-8.181747,"eighty":-3.259642,"marketCap":141445675},{"date":"2023-12-22","current":-4.123134,"twenty":-16.555414,"median":-8.181747,"eighty":-3.267442,"marketCap":133448746},{"date":"2023-12-29","current":-4.385655,"twenty":-16.555414,"median":-8.188189,"eighty":-3.27978,"marketCap":141945483},{"date":"2024-01-05","current":-3.72163,"twenty":-16.555414,"median":-8.194631,"eighty":-3.300075,"marketCap":120453737},{"date":"2024-01-12","current":-3.798842,"twenty":-16.555414,"median":-8.194631,"eighty":-3.310738,"marketCap":122952777},{"date":"2024-01-19","current":-3.690745,"twenty":-16.555414,"median":-8.203542,"eighty":-3.323991,"marketCap":119454121},{"date":"2024-01-26","current":-4.138576,"twenty":-16.555414,"median":-8.194631,"eighty":-3.334233,"marketCap":133948554},{"date":"2024-02-02","current":-4.231231,"twenty":-16.555414,"median":-8.194631,"eighty":-3.34328,"marketCap":136947402},{"date":"2024-02-09","current":-4.401098,"twenty":-16.555414,"median":-8.194631,"eighty":-3.378353,"marketCap":142445291},{"date":"2024-02-16","current":-4.102727,"twenty":-16.555414,"median":-8.194631,"eighty":-3.410709,"marketCap":127390985},{"date":"2024-02-23","current":-3.755038,"twenty":-16.555414,"median":-8.194631,"eighty":-3.422786,"marketCap":116595138},{"date":"2024-03-01","current":-3.615963,"twenty":-16.555414,"median":-8.188189,"eighty":-3.428196,"marketCap":112276800},{"date":"2024-03-08","current":-3.963652,"twenty":-16.555414,"median":-8.188189,"eighty":-3.470535,"marketCap":123072646},{"date":"2024-03-15","current":-3.668116,"twenty":-16.555414,"median":-8.188189,"eighty":-3.470535,"marketCap":113896177},{"date":"2024-03-22","current":-3.285659,"twenty":-16.555414,"median":-8.188189,"eighty":-3.459169,"marketCap":102020746},{"date":"2024-03-28","current":-3.285659,"twenty":-16.555414,"median":-8.188189,"eighty":-3.423904,"marketCap":102020746},{"date":"2024-04-05","current":-3.024892,"twenty":-16.555414,"median":-8.194631,"eighty":-3.397101,"marketCap":93923861},{"date":"2024-04-12","current":-2.885817,"twenty":-16.555414,"median":-8.194631,"eighty":-3.339444,"marketCap":89605523},{"date":"2024-04-19","current":-2.607666,"twenty":-16.555414,"median":-8.194631,"eighty":-3.324821,"marketCap":80968846},{"date":"2024-04-26","current":-2.520743,"twenty":-16.555414,"median":-8.158065,"eighty":-3.320187,"marketCap":78269884},{"date":"2024-05-03","current":-2.572897,"twenty":-16.555414,"median":-8.063626,"eighty":-3.305715,"marketCap":79889261},{"date":"2024-05-10","current":-2.62505,"twenty":-16.555414,"median":-7.973149,"eighty":-3.284927,"marketCap":81508638},{"date":"2024-05-17","current":-2.523034,"twenty":-16.555414,"median":-7.880326,"eighty":-3.268572,"marketCap":75570923},{"date":"2024-05-24","current":-2.288752,"twenty":-16.555414,"median":-7.880326,"eighty":-3.257706,"marketCap":68553623},{"date":"2024-05-31","current":-2.180622,"twenty":-16.555414,"median":-7.880326,"eighty":-3.236893,"marketCap":65314869},{"date":"2024-06-07","current":-2.314496,"twenty":-16.555414,"median":-7.880326,"eighty":-3.221739,"marketCap":69324719},{"date":"2024-06-14","current":-2.332578,"twenty":-16.555414,"median":-7.8854,"eighty":-3.215662,"marketCap":69866318},{"date":"2024-06-21","current":-2.224086,"twenty":-16.555414,"median":-7.793671,"eighty":-3.181352,"marketCap":66616722},{"date":"2024-06-28","current":-2.133676,"twenty":-16.56918,"median":-7.730784,"eighty":-3.173129,"marketCap":63908725},{"date":"2024-07-05","current":-1.98902,"twenty":-16.56918,"median":-7.646826,"eighty":-3.154082,"marketCap":59575930},{"date":"2024-07-12","current":-2.242168,"twenty":-16.56918,"median":-7.50542,"eighty":-3.134102,"marketCap":67158321},{"date":"2024-07-15","current":-2.314496,"twenty":-16.56918,"median":-7.491698,"eighty":-3.128727,"marketCap":69324719},{"date":"2024-08-02","current":-2.688567,"twenty":-16.607352,"median":-7.295099,"eighty":-3.110886,"marketCap":80529027},{"date":"2024-08-09","current":-2.323015,"twenty":-16.607352,"median":-7.150096,"eighty":-3.099278,"marketCap":69579874},{"date":"2024-08-16","current":-2.27142,"twenty":-16.607352,"median":-6.843832,"eighty":-3.09443,"marketCap":66100881},{"date":"2024-08-23","current":-2.345527,"twenty":-16.607352,"median":-6.688854,"eighty":-3.070128,"marketCap":68257484},{"date":"2024-08-30","current":-2.292699,"twenty":-16.607352,"median":-6.596464,"eighty":-3.04486,"marketCap":66720153},{"date":"2024-09-06","current":-2.303265,"twenty":-16.607352,"median":-6.46689,"eighty":-3.041239,"marketCap":67027619},{"date":"2024-09-13","current":-2.535705,"twenty":-16.607352,"median":-6.274951,"eighty":-3.024892,"marketCap":73791874},{"date":"2024-09-20","current":-2.324396,"twenty":-16.607352,"median":-6.057367,"eighty":-2.994322,"marketCap":67642551},{"date":"2024-09-27","current":-2.218741,"twenty":-16.607352,"median":-5.699353,"eighty":-2.972739,"marketCap":64567890},{"date":"2024-10-04","current":-2.303265,"twenty":-16.607352,"median":-5.568012,"eighty":-2.95642,"marketCap":67027619},{"date":"2024-10-11","current":-2.134218,"twenty":-16.607352,"median":-5.39486,"eighty":-2.919808,"marketCap":62108161},{"date":"2024-10-18","current":-2.007433,"twenty":-16.607352,"median":-5.332349,"eighty":-2.918118,"marketCap":58418567},{"date":"2024-10-25","current":-1.91171,"twenty":-16.607352,"median":-5.243092,"eighty":-2.890338,"marketCap":55632924},{"date":"2024-10-31","current":-1.897341,"twenty":-16.607352,"median":-5.044113,"eighty":-2.883743,"marketCap":55214770},{"date":"2024-11-08","current":-1.478527,"twenty":-16.609949,"median":-4.981516,"eighty":-2.848594,"marketCap":43026812},{"date":"2024-11-15","current":-1.18354,"twenty":-16.609949,"median":-4.934298,"eighty":-2.836112,"marketCap":34442357},{"date":"2024-11-22","current":-1.277361,"twenty":-16.609949,"median":-4.898885,"eighty":-2.816927,"marketCap":37172656},{"date":"2024-11-29","current":-1.391679,"twenty":-16.609949,"median":-4.828057,"eighty":-2.773442,"marketCap":40499440},{"date":"2024-12-06","current":-1.228732,"twenty":-16.609949,"median":-4.756274,"eighty":-2.752046,"marketCap":35757501},{"date":"2024-12-13","current":-1.616384,"twenty":-16.609949,"median":-4.688829,"eighty":-2.728223,"marketCap":47038597},{"date":"2024-12-20","current":-1.677557,"twenty":-16.609949,"median":-4.668862,"eighty":-2.705881,"marketCap":48818815},{"date":"2024-12-27","current":-1.545563,"twenty":-16.609949,"median":-4.632739,"eighty":-2.704326,"marketCap":44977627},{"date":"2025-01-03","current":-0.909709,"twenty":-16.609949,"median":-4.608851,"eighty":-2.687028,"marketCap":26473567},{"date":"2025-01-10","current":-0.803368,"twenty":-16.612546,"median":-4.588407,"eighty":-2.645781,"marketCap":23378922},{"date":"2025-01-17","current":-1.07211,"twenty":-16.612546,"median":-4.535819,"eighty":-2.62505,"marketCap":29568709},{"date":"2025-01-24","current":-1.05142,"twenty":-16.56918,"median":-4.511084,"eighty":-2.607666,"marketCap":28998085},{"date":"2025-01-31","current":-1.073453,"twenty":-16.521638,"median":-4.464712,"eighty":-2.573626,"marketCap":29605762},{"date":"2025-02-07","current":-1.056257,"twenty":-16.393722,"median":-4.436345,"eighty":-2.54602,"marketCap":29131477},{"date":"2025-02-14","current":-1.088501,"twenty":-16.278983,"median":-4.396899,"eighty":-2.522118,"marketCap":30020762},{"date":"2025-02-21","current":-1.168806,"twenty":-16.266724,"median":-4.365891,"eighty":-2.492369,"marketCap":32660481},{"date":"2025-02-28","current":-0.910729,"twenty":-16.242394,"median":-4.296201,"eighty":-2.463292,"marketCap":25448923},{"date":"2025-03-07","current":-0.94361,"twenty":-16.23404,"median":-4.238424,"eighty":-2.421882,"marketCap":26367741},{"date":"2025-03-14","current":-0.834467,"twenty":-16.223526,"median":-4.180842,"eighty":-2.404906,"marketCap":23317885},{"date":"2025-03-21","current":-0.750191,"twenty":-16.223526,"median":-4.154019,"eighty":-2.366658,"marketCap":20962933},{"date":"2025-03-28","current":-0.660113,"twenty":-16.210733,"median":-4.131589,"eighty":-2.354732,"marketCap":18445837},{"date":"2025-04-04","current":-0.549587,"twenty":-16.210733,"median":-4.10798,"eighty":-2.345527,"marketCap":15357375},{"date":"2025-04-11","current":-0.582745,"twenty":-16.20979,"median":-4.099451,"eighty":-2.323015,"marketCap":16283913},{"date":"2025-04-17","current":-0.711507,"twenty":-16.20979,"median":-4.08831,"eighty":-2.314496,"marketCap":19881971},{"date":"2025-04-25","current":-0.892616,"twenty":-16.204563,"median":-4.047882,"eighty":-2.299154,"marketCap":24942778},{"date":"2025-05-02","current":-0.800795,"twenty":-16.13511,"median":-4.018336,"eighty":-2.288752,"marketCap":22376994},{"date":"2025-05-09","current":-0.767078,"twenty":-15.99124,"median":-3.989935,"eighty":-2.282134,"marketCap":21434805},{"date":"2025-05-16","current":-0.713502,"twenty":-15.908254,"median":-3.97813,"eighty":-2.279033,"marketCap":19457890},{"date":"2025-05-23","current":-0.463209,"twenty":-15.788121,"median":-3.938155,"eighty":-2.261003,"marketCap":12632151},{"date":"2025-05-30","current":-0.444379,"twenty":-15.734261,"median":-3.929696,"eighty":-2.243533,"marketCap":12118649},{"date":"2025-06-06","current":-0.444379,"twenty":-15.660477,"median":-3.894114,"eighty":-2.226223,"marketCap":12118649},{"date":"2025-06-13","current":-0.446262,"twenty":-15.565802,"median":-3.864616,"eighty":-2.218741,"marketCap":12169999},{"date":"2025-06-20","current":-0.431199,"twenty":-15.513687,"median":-3.827199,"eighty":-2.206176,"marketCap":11759198},{"date":"2025-06-25","current":-0.45756,"twenty":-15.420255,"median":-3.816287,"eighty":-2.18986,"marketCap":12478101}],"updateTime":1750933368938}}}